- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06956599
Hypersensitivity Reduction Efficacy: 5% Potassium Nitrate Toothpaste Compared to Colgate Cavity Protection Toothpaste
March 17, 2026 updated by: Colgate Palmolive
Clinical Investigation of Hypersensitivity Reduction Efficacy: 5% Potassium Nitrate Toothpaste Compared to Colgate Cavity Protection Toothpaste
Assess the clinical efficacy of 5% Potassium Nitrate Toothpaste (Colgate-Palmolive Company, New York, NY, USA) on providing dentinal hypersensitivity relief (tactile and air blast) in comparison to Colgate Cavity Protection Toothpaste (Colgate-Palmolive Company, New York, NY, USA) over an eight-week period
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 610041
- West China Dental Institute of Chengdu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male and female subjects, ages 18-70, inclusive.- Availability for the eight-week duration of the study.
- Two sensitive teeth, which must be anterior to the molars, and demonstrate cervical erosion/abrasion or gingival recession.
- Qualifying response to tactile stimuli (Yeaple probe) as defined by a score between 10-50 gms. of force.
- Qualifying response to the air blast stimuli as defined by a score of 2 or 3 on the Schiff Cold Air Sensitivity Scale.
- Subjects need to satisfy the qualifying response to stimuli for both the parameters assessed (tactile or air) on two teeth to be entered into the study.
- Good general health with no known allergies to products being tested.
- Use of a non-desensitizing dentifrice for three months prior to entry into the study.
- Signed Informed Consent Form
Exclusion Criteria:
- Gross oral pathology, chronic disease, or history of allergy to test products.
- Advanced periodontal disease or treatment for periodontal disease (including surgery) within the past twelve months.
- Sensitive teeth with a mobility greater than one.
- Teeth with extensive/defective restorations (including prosthetic crowns), suspected pulpitis, caries, cracked enamel, or used as abutments for removable partial dentures.
- Current use of anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory drugs, or daily use of analgesics.
- Participation in a desensitizing dentifrice study or regular use of a desensitizing dentifrice within the past three months.
- Current participation in any other clinical study.
- Pregnant or lactating subjects.
- Allergies to oral care products, personal care consumer products, or their ingredients.
- Medical condition which prohibits not eating/drinking for 4 hours.
- Use in the past of the three test dentifrices.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control toothpaste
Subjects will be instructed to brush their teeth with their assigned test dentifrice and toothbrush twice daily
|
A commercially available fluoride toothpaste
|
|
Experimental: Test Toothpaste
Subjects will be instructed to brush their teeth with their assigned test dentifrice and toothbrush twice daily
|
A commercially available fluoride toothpaste
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
tactile sensitivity
Time Frame: baseline and 4 weeks, 8 week measurement
|
tactile stimulation is measured by the Yeaple Electronic Force Sensing Probe
|
baseline and 4 weeks, 8 week measurement
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
air blast sensitivity
Time Frame: baseline and 4 weeks, 8 week measurement
|
air blast sensitivity is delivered by a standard dental unit syringe at a measured temperature of 19-21°C (70°F [± 3°F]) [sensitivity will be defined by a score of 2 or 3 on the Schiff Cold Air sensitivity scale Air Sensitivity Scale
|
baseline and 4 weeks, 8 week measurement
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2025
Primary Completion (Actual)
August 11, 2025
Study Completion (Actual)
August 11, 2025
Study Registration Dates
First Submitted
April 25, 2025
First Submitted That Met QC Criteria
May 1, 2025
First Posted (Actual)
May 4, 2025
Study Record Updates
Last Update Posted (Actual)
March 19, 2026
Last Update Submitted That Met QC Criteria
March 17, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRO-2025-04-SEN-PNT-YPZ
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dentin Hypersensitivity
-
Cairo UniversityCompletedDentin Hypersensitivity | Dentin Desensitizing Agents | Dentin Hypersensitivity, Non-carious Cervical LesionsEgypt
-
Federal University of UberlandiaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo...UnknownDentin Sensitivity | Dentin Hypersensitivity | Dentine Hypersensitivity | Hypersensitivity DentinBrazil
-
Federal University of UberlandiaCompletedDentin Sensitivity | Dentin Hypersensitivity | Dentine Hypersensitivity | Hypersensitivity DentinBrazil
-
Federal University of UberlandiaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo...UnknownDentin Sensitivity | Dentin Hypersensitivity | Dentine Hypersensitivity | Hypersensitivity DentinBrazil
-
Universidad del DesarrolloFlorencia PachecoUnknown
-
Cairo UniversityNot yet recruitingDentin Hypersensitivity | Tooth Hypersensitivity
-
University of Roma La SapienzaCompletedTo Decrease Dentin HypersensitivityItaly
-
University of Nove de JulhoUnknownHypersensitivity Dentin
-
HALEONRecruitingDentin HypersensitivityUnited States
-
Peking University Hospital of StomatologyCompleted
Clinical Trials on Control toothpaste
-
Unilever R&DRecruitingDental Plaque | Gingival Inflammation | Gingival BleedingIndonesia
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
Church & Dwight Company, Inc.CompletedDental CariesUnited States
-
Church & Dwight Company, Inc.CompletedDental CariesUnited States
-
GlaxoSmithKlineCompletedHypersensitivity | Dentinal SensitivityUnited States
-
Ministry of Health, Saudi ArabiaUnknown
-
Colgate PalmoliveCompletedDental Plaque and GingivitisDominican Republic
-
University of ZagrebUnknown
-
Colgate PalmoliveWithdrawn
-
Unilever R&DIntertekCompleted